Especially, CPE is effective in chemoresistant/recurrent ovarian cancer based on the high expression of claudin-3 and claudin-4 in chemoresistant/recurrent ovarian tumors [132]. This evidence concerns the gene CLDN4 and ovarian carcinoma.